TER-2013

· Terremoto Biosciences Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TER-2013, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations [Phase 1, Phase 2]

See pricing